Vivo Bio tech Ltd. · CashKonnect

About

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory IND preclinical development services; screening and evaluating molecules for various pharmacological properties; and designs and develops of syngeneic / xenograft models for evaluation of anti-cancer agents' evaluation. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India.

Key Metrics

as of Sep 2026

Market Cap42 Cr

P/E—

Div Yield0.00 %

Book Value₹42.00

52w High₹41.50

52w Low₹17.40

Face Value₹10.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	14.28	14.20	13.51	13.11	12.51	12.29	12.21	12.04	10.13	11.76	12.85	9.26	11.58
Expenses	9.23	9.75	8.02	7.69	7.03	7.27	6.67	6.45	5.77	6.39	6.48	4.40	7.09
Operating Profit	5.05	4.45	5.49	5.42	5.48	5.02	5.54	5.59	4.36	5.37	6.37	4.86	4.49
OPM %	35.36	31.34	40.64	41.34	43.80	40.85	45.37	46.43	43.04	45.66	49.57	52.48	38.77
Other Income	0.06	0.03	0.14	0.13	0.14	0.15	0.01	4.63	0.01	0.01	0.03	0.00	0.00
Depreciation	3.53	2.75	2.66	2.57	2.64	2.25	2.25	2.29	2.23	2.43	2.28	2.30	2.29
Interest	1.24	1.48	1.40	1.47	1.50	1.68	1.84	2.06	1.92	1.52	2.22	2.09	1.95
Profit before tax	0.34	0.25	1.57	1.51	1.48	1.24	1.46	5.87	0.22	1.43	1.90	0.47	0.25
Tax %	44.12	2,164.00	20.38	42.38	9.46	14.52	43.84	10.73	27.27	48.95	31.05	29.79	44.00
Net Profit	0.19	-5.16	1.25	0.87	1.34	1.06	0.82	5.23	0.17	0.74	1.32	0.33	0.14
EPS in Rs	0.09	-2.33	0.57	0.39	0.67	0.62	0.51	3.51	0.11	0.50	0.89	0.22	0.09

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	53.33	46.67	45.45	52.23	51.39	51.78	55.35	55.83	47.00	34.13	28.58	17.79
Expenses	32.48	26.11	24.19	30.39	35.30	33.98	42.88	46.32	36.11	26.51	24.87	14.99
Operating Profit	20.85	20.56	21.26	21.84	16.09	17.80	12.47	9.51	10.89	7.62	3.71	2.80
OPM %	39.10	44.05	46.78	41.82	31.31	34.38	22.53	17.03	23.17	22.33	12.98	15.74
Other Income	0.44	4.80	0.04	0.04	0.10	0.08	0.05	0.01	0.13	0.40	0.89	0.95
Interest	5.85	7.55	7.95	7.99	4.27	3.67	3.10	2.64	2.37	1.29	0.47	0.51
Depreciation	10.63	9.02	9.29	9.27	7.45	5.59	5.17	5.06	4.64	3.90	3.35	3.05
Profit before tax	4.81	8.79	4.06	4.62	4.47	8.62	4.25	1.82	4.01	2.83	0.78	0.19
Tax %	135.55	17.18	37.93	42.64	50.78	34.11	-4.47	-23.08	21.95	11.66	-16.67	-142.11
Net Profit	-1.71	7.28	2.53	2.65	2.20	5.68	4.44	2.25	3.12	2.50	0.91	0.46
EPS in Rs	-0.77	4.24	1.70	1.78	1.54	4.23	3.45	1.82	3.17	2.67	0.97	0.49
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	22.19	17.16	14.90	14.90	14.26	13.42	12.89	12.35	9.85	9.35	9.35	9.35
Reserves	70.97	60.74	39.50	36.97	32.87	29.11	20.14	14.92	9.46	3.22	0.71	-0.18
Borrowings	67.38	54.03	73.06	62.39	67.44	30.96	24.37	21.68	25.12	27.06	16.91	5.69
Other Liabilities	17.89	11.30	9.67	8.77	7.91	6.03	6.29	6.37	15.08	11.49	18.69	26.57
Total Liabilities	178.43	143.23	137.13	123.03	122.48	79.52	63.69	55.32	59.51	51.12	45.66	41.43
Fixed Assets	123.02	88.24	80.37	88.87	95.17	52.05	34.99	30.01	27.66	28.57	23.54	19.69
CWIP	4.81	12.84	9.21	1.90	0.87	0.32	0.15	0.07	3.94	2.96	0.04	0.07
Investments	21.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	28.69	42.15	47.55	32.26	26.44	27.15	28.55	25.24	27.91	19.59	22.08	21.67
Total Assets	178.43	143.23	137.13	123.03	122.48	79.52	63.69	55.32	59.51	51.12	45.66	41.43

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	11.83	15.52	14.83	16.64	14.18	8.61	-0.78	11.11	-5.66	8.81	2.25
Cash from Investing Activity	-15.84	-7.95	-4.00	-51.11	-22.82	-10.23	-3.53	-4.72	-11.84	-7.20	-2.04
Cash from Financing Activity	3.90	-7.56	-11.18	35.02	8.78	2.09	0.72	-3.43	6.83	-0.32	-0.89
Net Cash Flow	-0.11	0.01	-0.34	0.55	0.14	0.47	-3.59	2.96	-10.67	1.30	-0.68
Free Cash Flow	-4.01	7.57	10.83	-34.47	-8.64	-1.62	-4.31	6.39	-17.50	1.61	0.21
CFO/OP %	65.00	80.00	77.00	118.00	96.00	68.00	-13.00	110.00	-70.00	234.00	81.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Debtor Days	80.42	87.98	94.76	86.52	85.37	51.39	69.11	54.98	91.48	82.03	48.79	88.43
Inventory Days	365.90	491.08	831.44	429.70	312.99	672.29	451.13	255.75	289.48	204.47	169.23	557.61
Days Payable	88.00	61.78	100.49	50.68	74.02	70.37	166.72	152.08	304.36	242.14	362.93	814.41
Cash Conversion Cycle	358.32	517.29	825.71	465.53	324.35	653.31	353.52	158.65	76.61	44.36	-144.91	-168.38
Working Capital Days	-22.24	100.26	63.76	38.09	8.10	28.76	35.15	36.22	-13.28	19.25	-131.29	-353.72
ROCE %	7.29	9.04	9.94	11.02	9.29	18.78	13.82	9.55	15.18	12.37	5.98	4.67

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	30.62	35.43	35.17	35.17	39.07	40.85	38.89	42.08	42.08	42.08	42.08	42.08
Public	69.39	64.58	64.84	64.84	60.94	59.16	61.12	57.91	57.92	57.92	57.92	57.91
No. of Shareholders	21,225	21,427	21,622	21,647	21,865	21,935	21,167	19,545	18,852	18,971	15,615	13,006